glp 1 receptor agonists beyond their pancreatic effects GLP-1 are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP−1 Receptor Agonist Mechanisms GLP−1RAs
Description
The drug is in the same class of GLP-1 medications as Ozempic, Wegovy, Mounjaro, and Zepbound weekly injections that upended the weight-loss industry but in pill form
GLP-1s for Alcohol Use Disorder (AUD) Early research has included investigations to determine whether GLP-1 might be an effective treatment for AUD
PMC 304885
Until recently, the only effective treatment for obesity was bariatric surgery, and a century of drug development for obesity can be essentially described as a failure until now
Some people feel like they have fully returned to their pre-medication state
